statins / MUC1 Cancer Research Results

statins, statins: Click to Expand ⟱
Features:
Statins, inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, which act downstream of ACL in the cholesterol synthesis pathway, can dramatically enhance the anti-tumor effects of ACL inhibition.


MUC1, Mucin 1: Click to Expand ⟱
Source:
Type: oncoprotein
The mucin 1 (MUC1) heterodimeric oncoprotein is overexpressed in human prostate cancers with aggressive pathologic and clinical features, resulting in a poor MUC1 (Mucin 1) is a glycoprotein that is expressed on the surface of epithelial cells and plays a role in cell signaling, protection, and lubrication. It is also involved in various biological processes, including cell adhesion and immune response outcome.
MUC1 is often overexpressed in various types of cancers, including breast, ovarian, pancreatic, and colorectal cancers.


Scientific Papers found: Click to Expand⟱
1575- statins,  Citrate,    Inhibition of Lung Cancer Growth: ATP Citrate Lyase Knockdown and Statin Treatment Leads to Dual Blockade of Mitogen-Activated Protein Kinase (MAPK) and Phosphatidylinositol-3-Kinase (PI3K)/AKT Pathways
- in-vitro, NSCLC, A549
eff↑, HMG-CoA↓, eff↑, AntiTum↑, EGFR↓, eff↑, ROS↑, EMT↓, E-cadherin↑, MUC1↑, p‑ACLY↓, p‑Akt↓, eff↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

ROS↑, 1,  

Core Metabolism/Glycolysis

p‑ACLY↓, 1,   HMG-CoA↓, 1,  

Cell Death

p‑Akt↓, 1,  

Proliferation, Differentiation & Cell State

EMT↓, 1,  

Migration

E-cadherin↑, 1,   MUC1↑, 1,  

Angiogenesis & Vasculature

EGFR↓, 1,  

Drug Metabolism & Resistance

eff↑, 4,  

Clinical Biomarkers

EGFR↓, 1,  

Functional Outcomes

AntiTum↑, 1,  
Total Targets: 11

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: MUC1, Mucin 1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:18  Target#:206  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page